Case records of the Massachusetts General Hospital. Case 28-2010. A 32-year-old woman, 3 weeks post partum, with substernal chest pain.
N Engl J Med. 2010;363(12):1164-73 - PMID: 20843252 - DOI: 10.1056/NEJMcpc1000966
Renal Mass Biopsy to Guide Treatment Decisions for Small Incidental Renal Tumors: A Cost-effectiveness Analysis.
Monitoring of magnetic targeting to tumor vasculature through MRI and biodistribution.
Nanomedicine (Lond). 2010;5(8):1173-82 - PMID: 21039195 - DOI: 10.2217/nnm.10.84
Multitechnique imaging findings of prolene plug hernia repair.
AJR Am J Roentgenol. 2010;195(3):701-6 - PMID: 20729449 - DOI: 10.2214/AJR.09.4142
Imaging-guided percutaneous renal biopsy: rationale and approach.
AJR Am J Roentgenol. 2010;194(6):1443-9 - PMID: 20489082 - DOI: 10.2214/AJR.10.4427
Prostate cancer imaging: what the next decade holds.
Expert Rev Med Devices. 2010;7(5):577-9 - PMID: 20822379 - DOI: 10.1586/erd.10.43
Focal therapy in prostate cancer-report from a consensus panel.
J Endourol. 2010;24(5):775-80 - PMID: 20477543 - DOI: 10.1089/end.2009.0596
Evolving Role of Magnetic Resonance Imaging in Renal Cancer Imaging.
J Endourol. 2010;24(5):707-11 - PMID: 20433369 - DOI: 10.1089/end.2009.0507
Modalities in modern radiology: A synopsis.
J Postgrad Med. 2010;56(2):85-7 - PMID: 20622386 - DOI: 10.4103/0022-3859.65282
Pediatric imaging: Current and emerging techniques.
J Postgrad Med. 2010;56(2):98-102 - PMID: 20622388 - DOI: 10.4103/0022-3859.65273
Sonographic findings of an adrenal leiomyosarcoma.
J Ultrasound Med. 2010;29(9):1369-73 - PMID: 20733196 - DOI: 10.7863/jum.2010.29.9.1369
Appearance of primary lymphoid malignancies on lymphotropic nanoparticle-enhanced magnetic resonance imaging using ferumoxtran-10.
Clin Imaging. 2010;34(6):448-52 - PMID: 21092874 - DOI: 10.1016/j.clinimag.2009.09.008
Detection of lymph nodes in pelvic malignancies with computed tomography and magnetic resonance imaging.
Clin Imaging. 2010;34(5):361-6 - PMID: 20813300 - DOI: 10.1016/j.clinimag.2009.07.004
Detection of nodal metastatic disease in patients with non-small cell lung cancer: comparison of positron emission tomography (PET), contrast-enhanced computed tomography (CT), and combined PET-CT.
Clin Imaging. 2010;34(1):20-28 - PMID: 20122515 - DOI: 10.1016/j.clinimag.2009.03.012
Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients.
AJR Am J Roentgenol. 2009;193(4):1175-9 - PMID: 19770344 - DOI: 10.2214/AJR.08.1840
Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model.
AJR Am J Roentgenol. 2009;193(3):W230-7 - PMID: 19696264 - DOI: 10.2214/AJR.08.2175
Molecular imaging in urologic surgery.
Urol Clin N Am. 2009;36(2):125-32 - PMID: 19406314 - DOI: 10.1016/j.ucl.2009.02.007
The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.
Cancer Biomark. 2009;5(2):69-73 - PMID: 19414923 - DOI: 10.3233/CBM-2009-0579
Nanoparticle enhanced imaging.
Cancer Biomark. 2009;5(2):59 - PMID: 19414921 - DOI: 10.3233/CBM-2009-0614
Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles.
Cancer Biomark. 2009;5(2):99-107 - PMID: 19414927 - DOI: 10.3233/CBM-2009-0615
Overview of nanoparticle use in cancer imaging.
Cancer Biomark. 2009;5:61-7 - PMID: 19414922 - DOI: 10.3233/CBM-2009-0578
Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.
Clin Imaging. 2009;33(4):301-5 - PMID: 19559353 - DOI: 10.1016/j.clinimag.2009.01.013
22
CSV